You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Imatinib resistant

Showing 1 - 25 of 5,934
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Imatinib-resistant/Intolerant Chronic Myeloid Leukemia Treated

Completed
  • Chronic Myeloid Leukaemia
  • Rionero in Vulture, Potenza, Italy
  • +32 more
Oct 24, 2022

Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic

Recruiting
  • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +2 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 15, 2022

Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in Aichi (Nilotinib)

Completed
  • Chronic Myelogenous Leukemia
  • Acute Lymphoblastic Leukemia
  • Aichi, Japan
    Novartis Investigative Site
Dec 6, 2020

Gastrointestinal Stromal Tumors Trial in Worldwide (AMN107, STI571)

Completed
  • Gastrointestinal Stromal Tumors
  • AMN107, STI571
  • Boston, Massachusetts
  • +4 more
Dec 6, 2020

Gastrointestinal Stromal Tumors Trial in Worldwide (RAD001, Imatinib 600mg/day (Glevec is the brand name for imatinib), Imatinib

Completed
Has Results
  • Gastrointestinal Stromal Tumors
  • Boston, Massachusetts
  • +15 more
Jun 3, 2021

Progressive Gastrointestinal Stromal Tumor Trial in Germany (Imatinib mesylate)

Completed
  • Progressive Gastrointestinal Stromal Tumor
  • Imatinib mesylate
  • Berlin, Germany
  • +6 more
Sep 8, 2020

Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive) Trial in Tokyo (Nilotinib)

Completed
  • Chronic Myelogenous Leukemia
  • Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive)
  • Tokyo, Japan
    Novartis Investigative Site
Dec 6, 2020

Chronic Myeloid Leukemia, Chronic Phase, Adults Trial in Italy (Ponatinib)

Active, not recruiting
  • Chronic Myeloid Leukemia
  • +2 more
  • Alessandria, Italy
  • +36 more
Jan 4, 2022

Leukemia Trial in Los Angeles (dasatinib)

Completed
  • Leukemia
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center at UCLA
Jul 30, 2020

Leukemia Trial in Worldwide (Dasatinib)

Active, not recruiting
Has Results
  • Leukemia
  • Birmingham, Alabama
  • +173 more
Dec 1, 2022

Clinical Research of Drug Holiday Based on MRD Detection in GIST

Recruiting
  • Gastrointestinal Stromal Tumors
    • Beijing, Beijing, China
      Peking University People's Hospital
    May 11, 2023

    Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Worldwide (Nilotinib)

    Completed
    Has Results
    • Chronic Myeloid Leukemia
    • Acute Lymphoblastic Leukemia
    • Bordeaux, Aquitaine, France
    • +11 more
    Dec 6, 2020

    Gastrointestinal Stromal Tumors Trial in Seoul (Rivoceranib Mesylate, Paclitaxel)

    Not yet recruiting
    • Gastrointestinal Stromal Tumors
    • Rivoceranib Mesylate, Paclitaxel
    • Seoul, Korea, Republic of
      Asan Medical Center, University of Ulsan College of Medicine
    Jun 7, 2023

    Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive), Hypereosinophilic Syndrome Trial

    Completed
    Has Results
    • Chronic Myelogenous Leukemia
    • +3 more
    • Duarte, California
    • +100 more
    Jun 8, 2021

    Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Mixed Phenotype Acute Leukemia Trial in Worldwide (procedure,

    Recruiting
    • Acute Lymphoblastic Leukemia
    • +3 more
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +21 more
    • Birmingham, Alabama
    • +219 more
    Sep 15, 2022

    sCD62L and SPARC in Chronic Myeloid Leukemia Patients During

    Completed
    • Chronic Myeloid Leukemia
    • ELISA kit
    • Tanta, Egypt
      Tanta University
    May 18, 2022

    Second-line Pharmacotherapy Patterns and Outcomes of Advanced

    Not yet recruiting
    • Gastrointestinal Stromal Tumors
      • Guangzhou, Guangdong, China
        The first affiliated hospital,Sun yat-sen university
      Jun 30, 2022

      Treatment Free Remission (TFR) in CML Patients (CML-CP)Study

      Not yet recruiting
      • Chronic Myeloid Leukemia
      • Treatment-free Remission
      • TFR(Treatment-Free Remission)
      • (no location specified)
      Jun 27, 2022

      EGFR Gene Mutation, Nonsmall Cell Lung Cancer Trial in Washington, Hackensack (Dasatinib, Osimertinib)

      Active, not recruiting
      • EGFR Gene Mutation
      • Nonsmall Cell Lung Cancer
      • Washington, District of Columbia
      • +1 more
      Jan 9, 2022

      Gastrointestinal Stromal Tumors Trial in Seoul (Temozolomide capsule)

      Not yet recruiting
      • Gastrointestinal Stromal Tumors
      • Temozolomide capsule
      • Seoul, Korea, Republic of
        Asan Medical Center, University of Ulsan College of Medicine
      Dec 14, 2022

      GIST: Assessment of Tumor Mutations and TKI Plasma Exposure

      Recruiting
      • Gastro-intestinal Stromal Tumor
      • Vena puncture for blood collection
      • Tumor biopsy
      • Amsterdam, Netherlands
      • +4 more
      May 17, 2022

      Maximum Tolerated Dose, GIST, Metastatic Adult Soft Tissue Sarcoma Trial in Spain (Selinexor, Imatinib)

      Recruiting
      • Maximum Tolerated Dose
      • +4 more
      • Sevilla, Andalucia, Spain
      • +5 more
      Oct 21, 2020

      Acute Lymphoblastic Leukemia, Adult, Ph+ ALL, Newly Diagnosed Trial in Czechia (Ponatinib 15 MG Oral Tablet)

      Active, not recruiting
      • Acute Lymphoblastic Leukemia, Adult
      • +2 more
      • Ponatinib 15 MG Oral Tablet
      • Brno, Czechia
      • +6 more
      Nov 30, 2022

      Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia Trial in Worldwide (nilotinib)

      Completed
      Has Results
      • Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia
      • Loma Linda, California
      • +35 more
      Mar 25, 2021

      Chronic Phase Chronic Myeloid Leukemia Trial in Bruxelles (Ponatinib 30 mg QD, Ponatinib 15 mg QD, Nilotinib 400 mg BID)

      Terminated
      Has Results
      • Chronic Phase Chronic Myeloid Leukemia
      • Ponatinib 30 mg QD
      • +2 more
      • Bruxelles, Belgium
        Cliniques Universitaire Saint-Luc (Site 058)
      Oct 28, 2021